FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1990289715> ?p ?o ?g. }

• W1990289715 endingPage "134" @default.
• W1990289715 startingPage "130" @default.
• W1990289715 abstract "This prospective, single-center study assesses progression-free survival (PFS) and overall survival (OS) in patients with recurrent glioblastoma multiforme (GBM) treated with a single dose of superselective intra-arterial cerebral infusion (SIACI) of bevacizumab (BV) after blood-brain barrier disruption (BBBD). Patients were initially enrolled in our phase I study, for which the primary end point was to determine the safety and maximum tolerated dose of SIACI BV.Fourteen patients with recurrent GBM were recruited between August 2009 and November 2010 after failing the standard treatment with radiation therapy and temozolomide. None of these patients were previously treated with BV. After receiving a single dose of IA BV (2 to 15 mg/kg), standard IV BV chemotherapy was continued in 12 of 14 patients (86%). The recently updated Response Assessment in Neuro-Oncology Working Group (RANO) criteria were used to evaluate PFS, and the Kaplan-Meier estimator was used to evaluate PFS and OS.Using RANO criteria, the median PFS in these patients was 10 months. The median OS estimation for this cohort was 8.8 months. The OS was less than the PFS because 4 patients died without progressing. Toxicity attributed to the IA BV treatment was present in 2 patients (wound dehiscence and rash). Another patient suffered from seizures 1 week after the SIACI procedure; however, this patient had epilepsy before and seizure type/frequency were similar before and after therapy.Our study shows that for patients naïve to BV, a single dose of SIACI BV after BBBD followed by IV BV offers an encouraging outcome in terms of PFS when compared with previous trials using IV BV with and without concomitant irinotecan (CPT-11). Larger phase II trials are warranted to determine whether repeated IA BV alone is superior to IV BV for recurrent GBM." @default.
• W1990289715 created "2016-06-24" @default.
• W1990289715 creator A5023278342 @default.
• W1990289715 creator A5024592292 @default.
• W1990289715 creator A5029242118 @default.
• W1990289715 creator A5030488048 @default.
• W1990289715 creator A5032808006 @default.
• W1990289715 creator A5048782315 @default.
• W1990289715 creator A5056646847 @default.
• W1990289715 creator A5065236954 @default.
• W1990289715 date "2012-01-01" @default.
• W1990289715 modified "2023-10-13" @default.
• W1990289715 title "Intra-Arterial Delivery of Bevacizumab after Blood-Brain Barrier Disruption for the Treatment of Recurrent Glioblastoma: Progression-Free Survival and Overall Survival" @default.
• W1990289715 cites W1545750695 @default.
• W1990289715 cites W1858161324 @default.
• W1990289715 cites W1959628099 @default.
• W1990289715 cites W1981968613 @default.
• W1990289715 cites W1996494292 @default.
• W1990289715 cites W2001355942 @default.
• W1990289715 cites W2016621485 @default.
• W1990289715 cites W2020486016 @default.
• W1990289715 cites W2029470215 @default.
• W1990289715 cites W2036044314 @default.
• W1990289715 cites W2093783077 @default.
• W1990289715 cites W2100673960 @default.
• W1990289715 cites W2127745545 @default.
• W1990289715 cites W2132697290 @default.
• W1990289715 cites W2152387543 @default.
• W1990289715 cites W2158681922 @default.
• W1990289715 cites W2162643152 @default.
• W1990289715 cites W2163458899 @default.
• W1990289715 cites W2170367762 @default.
• W1990289715 doi "https://doi.org/10.1016/j.wneu.2011.05.056" @default.
• W1990289715 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3743246" @default.
• W1990289715 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22405392" @default.
• W1990289715 hasPublicationYear "2012" @default.
• W1990289715 type Work @default.
• W1990289715 sameAs 1990289715 @default.
• W1990289715 citedByCount "85" @default.
• W1990289715 countsByYear W19902897152012 @default.
• W1990289715 countsByYear W19902897152013 @default.
• W1990289715 countsByYear W19902897152014 @default.
• W1990289715 countsByYear W19902897152015 @default.
• W1990289715 countsByYear W19902897152016 @default.
• W1990289715 countsByYear W19902897152017 @default.
• W1990289715 countsByYear W19902897152018 @default.
• W1990289715 countsByYear W19902897152019 @default.
• W1990289715 countsByYear W19902897152020 @default.
• W1990289715 countsByYear W19902897152021 @default.
• W1990289715 countsByYear W19902897152022 @default.
• W1990289715 countsByYear W19902897152023 @default.
• W1990289715 crossrefType "journal-article" @default.
• W1990289715 hasAuthorship W1990289715A5023278342 @default.
• W1990289715 hasAuthorship W1990289715A5024592292 @default.
• W1990289715 hasAuthorship W1990289715A5029242118 @default.
• W1990289715 hasAuthorship W1990289715A5030488048 @default.
• W1990289715 hasAuthorship W1990289715A5032808006 @default.
• W1990289715 hasAuthorship W1990289715A5048782315 @default.
• W1990289715 hasAuthorship W1990289715A5056646847 @default.
• W1990289715 hasAuthorship W1990289715A5065236954 @default.
• W1990289715 hasBestOaLocation W19902897152 @default.
• W1990289715 hasConcept C126322002 @default.
• W1990289715 hasConcept C141071460 @default.
• W1990289715 hasConcept C143998085 @default.
• W1990289715 hasConcept C168563851 @default.
• W1990289715 hasConcept C188816634 @default.
• W1990289715 hasConcept C203092338 @default.
• W1990289715 hasConcept C2776694085 @default.
• W1990289715 hasConcept C2777389519 @default.
• W1990289715 hasConcept C2777802072 @default.
• W1990289715 hasConcept C2780739268 @default.
• W1990289715 hasConcept C509974204 @default.
• W1990289715 hasConcept C71924100 @default.
• W1990289715 hasConceptScore W1990289715C126322002 @default.
• W1990289715 hasConceptScore W1990289715C141071460 @default.
• W1990289715 hasConceptScore W1990289715C143998085 @default.
• W1990289715 hasConceptScore W1990289715C168563851 @default.
• W1990289715 hasConceptScore W1990289715C188816634 @default.
• W1990289715 hasConceptScore W1990289715C203092338 @default.
• W1990289715 hasConceptScore W1990289715C2776694085 @default.
• W1990289715 hasConceptScore W1990289715C2777389519 @default.
• W1990289715 hasConceptScore W1990289715C2777802072 @default.
• W1990289715 hasConceptScore W1990289715C2780739268 @default.
• W1990289715 hasConceptScore W1990289715C509974204 @default.
• W1990289715 hasConceptScore W1990289715C71924100 @default.
• W1990289715 hasIssue "1" @default.
• W1990289715 hasLocation W19902897151 @default.
• W1990289715 hasLocation W19902897152 @default.
• W1990289715 hasLocation W19902897153 @default.
• W1990289715 hasLocation W19902897154 @default.
• W1990289715 hasOpenAccess W1990289715 @default.
• W1990289715 hasPrimaryLocation W19902897151 @default.
• W1990289715 hasRelatedWork W2117908127 @default.
• W1990289715 hasRelatedWork W2169869816 @default.
• W1990289715 hasRelatedWork W2171714209 @default.
• W1990289715 hasRelatedWork W2302413146 @default.
• W1990289715 hasRelatedWork W2413916090 @default.
• W1990289715 hasRelatedWork W2767742536 @default.

• next